| psychiatric symptoms |
phenotype |
7 |
4 |
|
| psychiatric traits |
phenotype |
29 |
18 |
|
| psychoactive substances |
drug |
5 |
3 |
other psychoactive substances, psychoactive substances |
| psycholeptics |
drug |
2 |
1 |
ATC code N05 |
| psychological distress |
phenotype |
15 |
10 |
psychological distress |
| psychological function |
phenotype |
9 |
7 |
mental function, psychological function, psychological functioning |
| psychological health |
phenotype |
2 |
1 |
psychological health |
| psychological problems |
phenotype |
5 |
2 |
negative mental health outcomes |
| psychomotor speed |
phenotype |
3 |
2 |
psychomotor speed |
| psychopathology |
phenotype |
48 |
29 |
adverse mental health outcomes, associated psychopathology, lifetime psychopathology, mental disorder, mental health disorders, other types of psychopathology, psychopathological outcomes, psychopathology |
| psychopathy |
phenotype |
5 |
2 |
psychopathic traits, psychopathy |
| Psychoses |
phenotype |
3 |
— |
Psychosis, psychoses |
| psychosis |
phenotype |
65 |
29 |
ICD-10 F2, ICD-8 295, ICD-8 297, ICD-8 298, ICD-9 295, ICD-9 297, ICD-9 298, history or symptoms of psychoses, persistent psychotic symptoms, psychosis, psychotic, psychotic disorder, psychotic disorder diagnoses, psychotic disorders, psychotic illness, psychotic symptoms, psychotomimetic effects, self-reported psychotic symptoms, severe psychotic reactions, substance-induced psychotic disorder, unspecified psychosis |
| Psychosocial factors |
phenotype |
8 |
5 |
|
| psychosocial problems |
phenotype |
3 |
2 |
|
| psychostimulants |
drug |
7 |
2 |
psychostimulant, psychostimulants |
| psychoticism |
phenotype |
4 |
2 |
|
| psychotropic medication |
drug |
21 |
4 |
medication, medication use, psychiatric medication, psychotropic, psychotropic drugs, psychotropic medication use |
| p-tau |
drug |
2 |
2 |
p-tau, phosphorylated tau |
| PTBP2 |
gene |
3 |
2 |
|
